Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Pacific Biosciences (PACB)

Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 585,700
  • Shares Outstanding, K 301,907
  • Annual Sales, $ 154,010 K
  • Annual Income, $ -309,850 K
  • EBIT $ -191 M
  • EBITDA $ 34 M
  • 60-Month Beta 2.20
  • Price/Sales 4.02
  • Price/Cash Flow N/A
  • Price/Book 16.15

Options Overview Details

View History
  • Implied Volatility 117.62% (+2.32%)
  • Historical Volatility 66.86%
  • IV Percentile 55%
  • IV Rank 10.42%
  • IV High 412.87% on 04/16/25
  • IV Low 83.27% on 08/25/25
  • Expected Move (DTE 3) 0.1700 (8.46%)
  • Put/Call Vol Ratio 0.30
  • Today's Volume 1,552
  • Volume Avg (30-Day) 2,060
  • Put/Call OI Ratio 0.11
  • Today's Open Interest 121,006
  • Open Int (30-Day) 122,798
  • Expected Range 1.8400 to 2.1800

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.19
  • Number of Estimates 1
  • High Estimate -0.19
  • Low Estimate -0.19
  • Prior Year -0.20
  • Growth Rate Est. (year over year) +5.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.6700 +20.36%
on 12/29/25
2.2200 -9.46%
on 01/07/26
-0.1100 (-5.19%)
since 12/12/25
3-Month
1.4200 +41.55%
on 10/13/25
2.7200 -26.24%
on 11/25/25
+0.5900 (+41.55%)
since 10/10/25
52-Week
0.8500 +136.47%
on 05/28/25
2.7200 -26.24%
on 11/25/25
-0.0900 (-4.29%)
since 01/10/25

Most Recent Stories

More News
PacBio Announces Plans for Collaboration With n-Lorem Foundation and EspeRare to Advance Precision Therapies for Rare Genetic Diseases

MENLO PARK, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world's most advanced sequencing technologies, today announced plans to pursue a strategic collaboration...

PACB : 2.0100 (+3.61%)
PacBio Announces Preliminary Fourth Quarter and Full Year 2025 Revenue

MENLO PARK, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced preliminary unaudited revenue for the...

PACB : 2.0100 (+3.61%)
PacBio HiFi Adopted as First-Line Sequencing Approach to Investigate Sudden Unexplained Death in Childhood (SUDC)

MENLO PARK, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world's most advanced sequencing technologies, today announced that a UW Medicine and Seattle Children’s...

PACB : 2.0100 (+3.61%)
3 Reasons to Sell PACB and 1 Stock to Buy Instead

3 Reasons to Sell PACB and 1 Stock to Buy Instead

PACB : 2.0100 (+3.61%)
PacBio and UC Davis Researchers Introduce CiFi, a New Long-Read 3C Method That Enables Chromosome-Scale Assemblies from a Single SMRT Cell

MENLO PARK, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world's most advanced sequencing technologies, today announced CiFi, a new community-developed method that...

PACB : 2.0100 (+3.61%)
3 Unprofitable Stocks That Concern Us

3 Unprofitable Stocks That Concern Us

ENOV : 26.95 (-9.20%)
PACB : 2.0100 (+3.61%)
BGS : 4.17 (unch)
PacBio (PACB) Stock Is Up, What You Need To Know

PacBio (PACB) Stock Is Up, What You Need To Know

PACB : 2.0100 (+3.61%)
Stocks making big moves this week: PacBio, Crocs, FuelCell Energy, AMC Entertainment, and ON24

Stocks making big moves this week: PacBio, Crocs, FuelCell Energy, AMC Entertainment, and ON24

ONTF : 7.97 (+0.13%)
FCEL : 7.55 (-0.40%)
PACB : 2.0100 (+3.61%)
CROX : 87.09 (+1.19%)
AMC : 1.7300 (+5.49%)
Stocks making big moves yesterday: FuelCell Energy, Corcept, and PacBio

Stocks making big moves yesterday: FuelCell Energy, Corcept, and PacBio

CORT : 37.36 (-0.37%)
FCEL : 7.55 (-0.40%)
PACB : 2.0100 (+3.61%)
Why Is PacBio (PACB) Stock Soaring Today

Why Is PacBio (PACB) Stock Soaring Today

PACB : 2.0100 (+3.61%)

Business Summary

Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time...

See More

Key Turning Points

3rd Resistance Point 2.4200
2nd Resistance Point 2.2700
1st Resistance Point 2.1400
Last Price 2.0100
1st Support Level 1.8600
2nd Support Level 1.7100
3rd Support Level 1.5800

See More

52-Week High 2.7200
Fibonacci 61.8% 2.0100
Last Price 2.0100
Fibonacci 50% 1.7900
Fibonacci 38.2% 1.5700
52-Week Low 0.8500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar